Focus on Vascular Neuro-Ophthalmic Diseases: Concepts, Diagnostic Methods, and Treatment Strategies

doi:10.3969/j.issn.1673-5765.2024.03.001

Abstract

Abstract: Vascular neuro-ophthalmic diseases refer to neuro-ophthalmic diseases caused by vascular dysfunction. They encompass visual impairments, abnormal eye movement, and pupillary abnormalities resulting from vascular factors. It is an interdisciplinary field merging neuro-ophthalmology and vascular neurology. Most patients with this kind of disease are first diagnosed in department of ophthalmology or emergency, and the clinical manifestations of vascular neuro-ophthalmic diseases exhibit characteristics of being acute, critical, and severe, similar to vascular diseases such as stroke. Due to the nature of this interdisciplinary field, the diagnosis and treatment of these diseases can be delayed or neglected. Enhancing awareness of new concepts in vascular neuro-ophthalmology diseases, focusing on novel diagnostic and therapeutic approaches in this intersecting field, and improving early recognition and accurate diagnosis and treatment capabilities through specialized development and interdisciplinary collaboration can significantly enhance clinical prognosis for patients.

Key words: Vascular neuro-ophthalmology; Neuro-ophthalmology; Concept; Treatment strategy

摘要： 血管神经眼科疾病泛指因血管功能障碍导致的神经眼科疾病，涵盖所有因血管因素导致的视功能障碍、眼球运动及瞳孔异常，是神经眼科学与血管神经病学的交叉领域。此类疾病患者多首诊于眼科或急诊，临床表现具有血管病（卒中）急、危、重的特点，由于是交叉学科，诊疗常迟滞和延误。提高对血管神经眼科疾病新概念的认识，聚焦这一交叉领域的新诊疗方法和策略，通过专科建设和学科协作，提升早期识别和精准诊疗能力，有助于最大限度地改善患者的临床预后。

关键词: 血管神经眼科; 神经眼科; 概念; 诊疗策略

CLC Number:

WU Songdi. Focus on Vascular Neuro-Ophthalmic Diseases: Concepts, Diagnostic Methods, and Treatment Strategies[J]. Chinese Journal of Stroke, 2024, 19(3): 245-254.

吴松笛. 关注血管神经眼科疾病——概念、诊疗方法及策略[J]. 中国卒中杂志, 2024, 19(3): 245-254.

References

[1] LAMIREL C，NEWMAN N J，BIOUSSE V. Vascular neuro-ophthalmology[J]. Neurol Clin，2010，28（3）：701-727.
[2] 张晓君，田国红. 血管神经眼科学[J]. 中国卒中杂志，2011，6（7）：509-513.
ZHANG X J，TIAN G H. Vascular neuro-ophthalmology[J]. Chin J Stroke，2011，6（7）：509-513.
[3] HAYREH S S. Vascular disorders in neuro-ophthalmology[J]. Curr Opin Neurol，2011，24（1）：6-11.
[4] 田国红，沙炎. 血管神经眼科学疾病浅析[J]. 中国眼耳鼻喉科杂志，2017，17（1）：71-76.
TIAN G H，SHA Y. Analysis of diseases of vascular neuro-ophthalmology[J]. Chin J Ophthalmol and Otorhinolaryngol，2017，17（1）：71-76.
[5] IORGA E R，COSTIN D. Vascular emergencies in neuro-ophthalmology[J]. Rom J Ophthalmol，2020，64（4）：323-332.
[6] PULA J H，YUEN C A. Eyes and stroke：the visual aspects of cerebrovascular disease[J]. Stroke Vasc Neurol，2017，2（4）：210-220.
[7] SAHONTA R，SEBASTIAN I，AARON S，et al. Eye signs in stroke[J/OL]. Ann Indian Acad Neurol，2022，25（Suppl 2）：S94-S100[2024-01-10]. https://doi.org/10.4103/aian.aian_157_22.
[8] HELBOE K S，EDDELIEN H S，KRUUSE C. Visual symptoms in acute stroke—a systematic review of observational studies[J/OL]. Clin Neurol Neurosurg，2023，229：107749[2024-01-10].
https://doi.org/10.1016/j.clineuro.2023.107749.
[9] 陆方，佘凯芩，梁莉聪. 充分发挥光相干断层扫描及其血管成像的临床应用价值，不断提升神经眼科疾病的诊治水平[J]. 中华眼底病杂志，2021，37（3）：169-172.
LU F，SHE K Q，LIANG L C. Applying optical coherence tomography and optical coherence tomography angiography to improve the diagnosis and treatment of neuro-ophthalmic diseases[J]. Chin J Ocul Fundus Dis，2021，37（3）：169-172.
[10] LO C，VUONG L N，MICIELI J A. Recent advances and future directions on the use of optical coherence tomography in neuro-ophthalmology[J]. Taiwan J Ophthalmol，2021，11（1）：3-15.
[11] SIEBERT E，ROSSEL-ZEMKOUO M，VILLRINGER K，et al. Detectability of retinal diffusion restriction in central retinal artery occlusion is linked to inner retinal layer thickness[J]. Clin Neuroradiol，2022，32（4）：1037-1044.
[12] WENZEL D A，POLI S，CASAGRANDE M，et al. Inner retinal layer hyperreflectivity is an early biomarker for acute central retinal artery occlusion
[J/OL]. Front Med（Lausanne），2022，9：854288
[2024-01-10]. https://doi.org/10.3389/fmed.2022.854288.
[13] MOGHIMI S，AFZALI M，AKBARI M，et al. Crowded optic nerve head evaluation with optical coherence tomography in anterior ischemic optic neuropathy[J]. Eye（Lond），2017，31（8）：1191-1198.
[14] SIBONY P A，KUPERSMITH M J，KARDON R H. Optical coherence tomography neuro-toolbox for the diagnosis and management of papilledema，optic disc edema，and pseudopapilledema[J]. J Neuroophthalmol，2021，41（1）：77-92.
[15] CAREY A R，BOSLEY T M，MILLER N R，et al. Use of en face optical coherence tomography to monitor papilledema in idiopathic intracranial hypertension：a pilot study[J]. J Neuroophthalmol，2021，41（2）：212-216.
[16] MOON Y，SONG M K，SHIN J W，et al. Optical coherence tomography angiography characteristics and predictors of visual outcomes in patients with acute and chronic nonarteritic anterior ischemic optic neuropathy[J/OL]. J Neuroophthalmol，2021，41（4）：e440-e450[2024-01-10]. https://doi.org/10.1097/WNO.0000000000001102.
[17] 霍燕，蔺雪梅，吴松笛. 逆行跨突触变性视神经病变的研究进展[J]. 中华眼底病杂志，2022，38（12）：1035-1038.
HUO Y，LIN X M，WU S D. Advances in transsynaptic retrograde degeneration of optic neuropathy[J]. Chin J Ocul Fundus Dis，2022，38（12）：1035-1038.
[18] ZHOU S W，ZHANG Y，NOAM N，et al. The impact of carotid endarterectomy on choriocapillaris perfusion[J/OL]. Invest Ophthalmol Vis Sci，2023，64（15）：42[2024-01-10]. https://doi.org/10.1167/iovs.64.15.42.
[19] LEE J Y，KIM J P，JANG H，et al. Optical coherence tomography angiography as a potential screening tool for cerebral small vessel diseases[J/OL]. Alzheimers Res Ther，2020，12（1）：73[2024-01-10]. https://doi.org/10.1186/s13195-020-00638-x.
[20] WANG X Q，ZHANG X B，GAN L Y，et al. Observation of fundus and optical coherence tomography angiography manifestations in carotid cavernous fistula patients[J]. Graefes Arch Clin Exp Ophthalmol，2021，259（9）：2573-2582.
[21] KENNEY R，LIU M L，HASANAJ L，et al. Normative data and conversion equation for spectral-domain optical coherence tomography in an international healthy control cohort[J]. J Neuroophthalmol，2022，42（4）：442-453.
[22] 范玉华，党超，余剑，等. 中国脑血管病临床管理指南（第2版）（节选）——第7章脑静脉血栓形成临床管理[J]. 中国卒中杂志，2023，18（9）：1030-1035.
FAN Y H，DANG C，YU J，et al. Chinese Stroke Association guidelines for clinical management of cerebrovascular diseases（second edition）（excerpt）—chapter seven clinical management of cerebral venous thrombosis[J]. Chin J Stroke，2023，18（9）：1030-1035.
[23] HOLBROOK J，SAINDANE A M. Imaging of intracranial pressure disorders[J]. Neurosurgery，2017，80（3）：341-354.
[24] 中国医师协会介入医师分会（临床诊疗指南专业委员会）神经介入专业委员会，中华医学会放射学分会介入学组. 颈动脉海绵窦瘘诊治中国专家共识[J]. 中华放射学杂志，2023，57（8）：827-835.
Interventionalists Committee on Neurointervention（Clinical Guidelines Committee）of Chinese Medical Doctor Association，Interventional Group of Chinese Society of Radiology of Chinese Medical Association. Expert consensus on the management of carotid-cavernous fistula[J]. Chin J Radiol，2023，57（8）：827-835.
[25] MOLLAN S P，DAVIES B，SILVER N C，et al. Idiopathic intracranial hypertension：consensus guidelines on management[J]. J Neurol Neurosurg Psychiatry，2018，89（10）：1088-1100.
[26] PETROULIA V D，BRUGGER D，HOEPNER R，et al. MRI signs helpful in the differentiation of patients with anterior ischaemic optic neuropathy and optic neuritis[J]. Br J Ophthalmol，2023，107（1）：121-126.
[27] AUNG A B，CHEN B S，WICKS J，et al. Presumptive idiopathic intracranial hypertension based on neuroimaging findings：a referral pattern study[J]. J Neuroophthalmol，2023，43（1）：55-62.
[28] CHEN L，SHEN Y，HUANG X，et al. MRI-based radiomics for differentiating orbital cavernous hemangioma and orbital schwannoma[J/OL]. Front Med（Lausanne），2021，8：795038[2024-01-10]. https://doi.org/10.3389/fmed.2021.795038.
[29] MILEA D，NAJJAR R P，ZHUBO J，et al. Artificial intelligence to detect papilledema from ocular fundus photographs[J]. N Engl J Med，2020，382（18）：1687-1695.
[30] VASSENEIX C，NUSINOVICI S，XU X X，et al. Deep learning system outperforms clinicians in identifying optic disc abnormalities[J]. J Neuroophthalmol，2023，43（2）：159-167.
[31] LI A F，TANDON A K，SUN G，et al. Early detection of optic nerve changes on optical coherence tomography using deep learning for risk-stratification of papilledema and glaucoma[J]. J Neuroophthalmol，2024，44（1）：47-52.
[32] BO Z H，QIAO H，TIAN C，et al. Toward human intervention-free clinical diagnosis of intracranial aneurysm via deep neural network[J/OL]. Patterns（N Y），2021，2（2）：100197[2024-01-10]. https://doi.org/10.1016/j.patter.2020.100197.
[33] ZIPORI A B，KERLEY C I，KLEIN A，et al. Real-world translation of artificial intelligence in neuro-ophthalmology：the challenges of making an artificial intelligence system applicable to clinical practice[J]. J Neuroophthalmol，2022，42（3）：287-291.
[34] DUMITRASCU O M，WANG Y，CHEN J J. Clinical machine learning modeling studies：methodology and data reporting[J]. J Neuroophthalmol，2022，42（2）：145-148.
[35] 逯青丽，吴松笛. 视网膜动脉阻塞：“视网膜卒中”的认识与挑战[J]. 中国卒中杂志，2023，18（6）：712-719.
LU Q L，WU S D. Retinal artery occlusion：knowledge and challenge of“retinal stroke”[J]. Chin J Stroke，2023，18（6）：712-719.
[36] MAC GRORY B，SCHRAG M，BIOUSSE V，et al. Management of central retinal artery occlusion：a scientific statement from the American Heart Association[J/OL]. Stroke，2021，52（6）：e282-e294[2024-01-10]. https://doi.org/10.1161/STR.0000000000000366.
[37] RABER F P，GMEINER F V，DREYHAUPT J，et al. Thrombolysis in central retinal artery occlusion：a retrospective observational study[J]. J Neurol，2023，270（2）：891-897.
[38] SCHRAG M，YOUN T，SCHINDLER J，et al. Intravenous fibrinolytic therapy in central retinal artery occlusion：a patient-level meta-analysis[J]. JAMA Neurol，2015，72（10）：1148-1154.
[39] GAILLOUD P，MILLER N R. New and emerging interventional neuroradiologic techniques for neuro-opthalmologic disorders[J]. J Neuroophthalmol，2013，33（3）：282-295.
[40] ESKEY C J，MEYERS P M，NGUYEN T N，et al. Indications for the performance of intracranial endovascular neurointerventional procedures：a scientific statement from the American Heart Association[J/OL]. Circulation，2018，137（21）：e661-e689[2024-01-10].
https://doi.org/10.1161/CIR.0000000000000567.
[41] PAGE P S，KHATTAR N K，WHITE A C，et al. Intra-arterial thrombolysis for acute central retinal artery occlusion：a systematic review and meta-analysis[J/OL]. Front Neurol，2018，9：76[2024-01-10]. https://doi.org/10.3389/fneur.2018.00076.
[42] GAO Y，ZHAO W B，WU D，et al. Intra-arterial thrombolysis for acute retinal ischemia：a retrospective，observational，cohort study[J]. J Neuroophthalmol，2023，43（2）：202-208.
[43] HENDERSON A D，MILLER N R. Carotid-cavernous fistula：current concepts in aetiology，investigation，and management[J]. Eye（Lond），2018，32（2）：164-172.
[44] AL-SMADI A S，ALI R，KAPPEL A D，et al. Patch technique for primary treatment of type a carotid cavernous fistula：a case series and technical notes[J]. J Neuroophthalmol，2023，43（4）：541-546.
[45] DINKIN M J，PATSALIDES A. Idiopathic intracranial venous hypertension：toward a better understanding of venous stenosis and the role of stenting in idiopathic intracranial hypertension[J]. J Neuroophthalmol，2023，43（4）：451-463.
[46] 逯青丽，张咪，蔺雪梅，等. 静脉窦支架置入手术治疗暴发性特发性颅内压增高症1例[J]. 中华眼底病杂志，2023，39（4）：334-336.
LU Q L，ZHANG M，LIN X M，et al. A case of fulminant idiopathic intracranial hypertension treated by venous sinus stent implantation[J]. Chin J Ocul Fundus Dis，2023，39（4）：334-336.
[47] HOREV A，BEN-ARIE G，WALTER E，et al. Emergent cerebral venous stenting：a valid treatment option for fulminant idiopathic intracranial hypertension[J/OL]. J Neurol Sci，2023，452：120761[2024-01-10]. https://doi.org/10.1016/j.jns.2023.120761.
[48] QUEALY J B. Mechanical thrombectomy for aseptic，atraumatic，medically refractory cerebral venous sinus thrombosis：a systematic review[J/OL]. Clin Neuroradiol，2024[2024-01-10]. https://doi.org/10.1007/s00062-023-01373-0.
[49] MICIELI J A，NEWMAN N J，BARROW D L，et al. Intracranial aneurysms of neuro-ophthalmologic relevance[J]. J Neuroophthalmol，2017，37（4）：421-439.
[50] TOCCACELI G，DIANA F，CAGNAZZO F，et al. Microsurgical clipping compared with new and most advanced endovascular techniques in the treatment of unruptured middle cerebral artery aneurysms：a meta-analysis in the modern era[J/OL]. World Neurosurg. 2020，137：451-464，e1[2024-01-10]. https://doi.org/10.1016/j.wneu.2019.12.118.